DarioHealth (DRIO) vs Retractable Technologies (RVP)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Retractable Technologies (RVP) has outperformed DarioHealth (DRIO) over the past year, losing 30.3% versus a loss of 90.5%. Over five years, RVP leads with a -93.6% price change compared with -99.6% for DRIO. Retractable Technologies is the larger company by market cap ($16.7 million vs $14.9 million), about 1.1 times the size.
Retractable Technologies converts more of its revenue into profit, with a net margin of -32.8% versus -186.6%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | DRIO | RVP |
|---|---|---|
| Share price | $1.32 | $0.558 |
| Market cap | $14.90M | $16.70M |
| 1-day change | -8.33% | -6.84% |
| YTD return | -88.40% | -27.53% |
| 1-year return | -90.51% | -30.25% |
| 5-year return | -99.58% | -93.62% |
| EPS (TTM) | $-3.53 | $-0.19 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $22.36M | $38.27M |
| Revenue growth (YoY) | -17.31% | +15.78% |
| Net income (latest FY) | $-41.71M | $-12.57M |
| Gross margin | 56.64% | 0.12% |
| Operating margin | -163.94% | -55.34% |
| Net margin | -186.56% | -32.84% |
| 52-week high | $14.49 | $0.87 |
| 52-week low | $1.09 | $0.53 |
| Distance from 52-week high | -90.89% | -35.86% |
| Analyst consensus | strong_buy | — |
| Avg. price target upside | +930.30% | — |
| Average volume | 48.52K | 30.30K |
| Shares outstanding | 11.29M | 29.94M |
| Employees | 160 | 195 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- RVP has outperformed DRIO by 60.3 percentage points over the past year.
- Retractable Technologies is more profitable, keeping -32.8 cents of every revenue dollar as net income versus -186.6 cents for DarioHealth.
- Retractable Technologies grew revenue faster in its latest fiscal year (+15.78% vs -17.31%).
About DarioHealth
DRIO stock →DarioHealth Corp. operates as a digital health company in the United States and internationally.
Health Care · Medical/Dental Instruments · 160 employees
About Retractable Technologies
RVP stock →Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally.
Health Care · Medical/Dental Instruments · 195 employees
DRIO vs RVP FAQ
Which is bigger, DarioHealth or Retractable Technologies?
Retractable Technologies (RVP) is larger, with a market capitalization of $16.70M compared with $14.90M for DarioHealth (DRIO).
Which stock has performed better over the past year, DRIO or RVP?
RVP returned -30.25% over the past 12 months, compared with -90.51% for DRIO (price return, excluding dividends). Past performance does not predict future results.
Are DarioHealth and Retractable Technologies in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.